RxSight (RXST) Free Cash Flow (2020 - 2026)

RxSight (RXST) has reported Free Cash Flow for 7 consecutive years, with -$11.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 94.39% year-over-year to -$11.5 million; the trailing twelve-month figure through Jun 2026 stood at -$27.2 million (down 30.1% YoY), and the FY2025 full-year result was -$19.3 million, up 13.6% from the prior year.
• Free Cash Flow rose to -$11.5 million in Q2 2026 per RXST's latest filing, from -$11.6 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$453000.0 in Q3 2024 and bottomed at -$18.5 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$9.6 million across 5 years, with a median of -$9.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Free Cash Flow jumped 94.75% in 2024, then tumbled 290.29% in 2025.
• Over 5 years, Free Cash Flow stood at -$14.2 million in 2022, then soared by 30.42% to -$9.9 million in 2023, then soared by 48.37% to -$5.1 million in 2024, then surged by 55.88% to -$2.3 million in 2025, then tumbled by 410.16% to -$11.5 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$11.5 million, -$11.6 million, and -$2.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.